Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR4 | O95977 | 7/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | ELANE | P08246 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 3/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 3/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.31 |
| ▸ | AR | P10275 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | PLA2G7 | Q13093 | 1/20 | 0.31 |
| ▸ | HTR1A | P08908 | 1/20 | 0.31 |
| ▸ | HTR7 | P34969 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
| ▸ | ACHE | P22303 | 1/20 | 0.30 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5349857 | 0.87 | ELANE (0.33) | ALDH1A1SMN1; SMN2ELANEGAAMAPT | |
| SCHEMBL5343488 | 0.83 | PRKCQ (0.30) | MAPT | |
| SCHEMBL29767630 | 0.83 | HTR7 (0.38) | ALDH1A1SMN1; SMN2TDP1MEN1KMT2A | |
| SCHEMBL5344329 | 0.83 | HTR7 (0.38) | ALDH1A1SMN1; SMN2TDP1MEN1KMT2A | |
| SCHEMBL28424456 | 0.81 | HTR7 (0.37) | ALDH1A1SMN1; SMN2TDP1MEN1KMT2A | |
| SCHEMBL26606283 | 0.80 | CA1 (0.34) | ALDH1A1CYP1A2 | |
| SCHEMBL6652909 | 0.80 | — | — | |
| SCHEMBL5344544 | 0.79 | FYN (0.40) | ALDH1A1SMN1; SMN2MAPTACHE | |
| SCHEMBL5344039 | 0.79 | POLB (0.31) | — | |
| SCHEMBL2233714 | 0.79 | ALDH1A1 (0.34) | ALDH1A1SMN1; SMN2GAAMAPTTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10005864-B2 | Metallocene compound, catalyst for olefin polymer, method for producing olefin polymer, and olefin polymer | JAPAN POLYETHYLENE CORPORATION (JP) | 2018-06-26 | — | — | US | disclosed |
| EP-3078670-B1 | METALLOCENE COMPOUND, CATALYST FOR OLEFIN POLYMER, METHOD FOR PRODUCING OLEFIN POLYMER, AND OLEFIN POLYMER | JAPAN POLYETHYLENE CORP (JP) | 2017-12-27 | — | — | EP | disclosed |
| US-20170320981-A1 | METALLOCENE COMPOUND, CATALYST FOR OLEFIN POLYMER, METHOD FOR PRODUCING OLEFIN POLYMER, AND OLEFIN POLYMER | JAPAN POLYETHYLENE CORPORATION (JP) | 2017-11-09 | — | — | US | disclosed |
| US-9783625-B2 | Metallocene compound, catalyst for olefin polymer, method for producing olefin polymer, and olefin polymer | JAPAN POLYETHYLENE CORPORATION (JP) | 2017-10-10 | — | — | US | disclosed |
| EP-2963045-B1 | METHOD FOR PRODUCING OLEFIN POLYMER WITH A METALLOCENE BASED CATALYST, AND OLEFIN POLYMER | JAPAN POLYETHYLENE CORP (JP) | 2016-12-21 | — | — | EP | disclosed |
| EP-3078670-A1 | METALLOCENE COMPOUND, CATALYST FOR OLEFIN POLYMER, METHOD FOR PRODUCING OLEFIN POLYMER, AND OLEFIN POLYMER | Japan Polyethylene Corporation (JP) | 2016-10-12 | — | — | EP | disclosed |
| US-20160009838-A1 | METALLOCENE COMPOUND, CATALYST FOR OLEFIN POLYMER, METHOD FOR PRODUCING OLEFIN POLYMER, AND OLEFIN POLYMER | JAPAN POLYETHYLENE CORPORATION (JP) | 2016-01-14 | — | — | US | disclosed |
| EP-2963045-A1 | METALLOCENE COMPOUND, CATALYST FOR OLEFIN POLYMER, METHOD FOR PRODUCING OLEFIN POLYMER, AND OLEFIN POLYMER | Japan Polyethylene Corporation (JP) | 2016-01-06 | — | — | EP | disclosed |
| US-7297747-B2 | Polymerization process and polymer composition | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2007-11-20 | — | — | US | disclosed |
| US-7122498-B2 | Metallocenes and catalyst compositions derived therefrom | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2006-10-17 | — | — | US | disclosed |
| US-6870016-B1 | Polymerization process and polymer composition | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2005-03-22 | — | — | US | disclosed |
| US-20050059785-A1 | Polymerization process and polymer composition | HART JAMES R (US) | 2005-03-17 | — | — | US | disclosed |
| US-20050054520-A1 | Metallocenes and catalyst compositions derived therefrom | EXXONMOBIL CHEMICAL PATENT INC. | 2005-03-10 | — | — | US | disclosed |
| EP-1421090-A2 | METALLOCENES AND CATALYST COMPOSITIONS DERIVED THEREFROM | Exxonmobil Chemical Patents Inc. (US) | 2004-05-26 | — | — | EP | disclosed |
| WO-2003002583-A2 | METALLOCENES AND CATALYST COMPOSITIONS DERIVED THEREFROM | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2003-01-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170320981-A1 | METALLOCENE COMPOUND, CATALYST FOR OLEFIN POLYMER, METHOD FOR PRODUCING OLEFIN POLYMER, AND OLEFIN POLYMER | CPNE4, PIN4, PIN1 | S1PR4 1573/4885ALDH1A1 2456/4885SMN1; SMN2 1338/4885 |
| US-20160009838-A1 | METALLOCENE COMPOUND, CATALYST FOR OLEFIN POLYMER, METHOD FOR PRODUCING OLEFIN POLYMER, AND OLEFIN POLYMER | CPNE4, ALOX12, PIN1 | S1PR4 2415/4885ALDH1A1 1383/4885SMN1; SMN2 1265/4885 |
| US-10005864-B2 | Metallocene compound, catalyst for olefin polymer, method for producing olefin polymer, and olefin polymer | CPNE4, PPOX, PIN1 | S1PR4 1570/4885ALDH1A1 2306/4885SMN1; SMN2 2346/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.